Catalog Number EX061703C |
Device Problems
Break (1069); Misfire (2532)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/17/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that during a stent placement procedure, the stent was started to release and stopped before accommodating.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.H10: d4 (expiry date: 05/2023).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device pending return.
|
|
Manufacturer Narrative
|
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the lifestent xl vascular stent products that are cleared in the us.The pro code and 510 k number for the lifestent xl vascular stent products are identified in d2 and g4.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: the sample was not returned for evaluation and no image was provided for review which leads to inconclusive evaluation result.The system compatible 6f introducer/0.035" guidewire were used for access, the vessel was not tortuous/calcified, the lesion was pre-dilated, and the user did not experience force increase during deployment.Based on the investigation of the provided information, the investigation is closed as inconclusive.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the relevant labeling for this product the potential issue was found addressed.The instructions for use state: 'if excessive force is felt during stent deployment, do not force the delivery system.Remove the delivery system and replace with a new unit'.Regarding accessories/access the instructions for use state: 'gain femoral access at the appropriate site using a 6f (2.0 mm) or larger introducer sheath.Insert a 0.035 inch (0.89 mm) diameter guidewire'.The instructions for use state: 'predilation of the lesion should be performed using standard techniques'.Holding and handling of the system throughout deployment was found sufficiently described; e.G.The instructions for use state: 'firmly hold the black system stability sheath throughout deployment.Note: do not hold the silver stent delivery sheath at any time during deployment.Do not constrict the stent delivery sheath during stent deployment.' h10: b5, d4 (expiration date: 05/2023), g3 h11: h6 (result, conclusion) h11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
|
|
Event Description
|
It was reported that during a stent placement procedure via the femoral artery access, the stent was started to release but had allegedly stopped before accommodating, and did not open.The procedure was completed using another device.There was no reported patient injury.
|
|
Event Description
|
It was reported that during a stent placement procedure via the femoral artery access, the stent was started to release but had allegedly stopped before accommodating, and did not open.The procedure was completed using another device.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the lifestent xl vascular stent products that are cleared in the us.The pro code and 510 k number for the lifestent xl vascular stent products are identified in d2 and g4.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: the sample was returned for evaluation.The returned sample was found in used condition with a minimal tip to sheath gap, and with partially deployed stent; a force transmitting component was found broken inside grip so that a successful deployment was impossible.The system compatible 6f introducer/ 0.035" guidewire were used for access, the vessel was not tortuous/ calcified, the lesion was pre dilated, and the user did not experience force increase during deployment.The investigation leads to confirmed result for break inside grip and cascading partial deployment.Based on the investigation of the provided information, the investigation is closed as confirmed.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the relevant labeling for this product the potential issue was found addressed.The instructions for use state: 'if excessive force is felt during stent deployment, do not force the delivery system.Remove the delivery system and replace with a new unit'.Regarding accessories/access the instructions for use state: 'gain femoral access at the appropriate site using a 6f (2.0 mm) or larger introducer sheath.Insert a 0.035 inch (0.89 mm) diameter guidewire'.The instructions for use state: 'predilation of the lesion should be performed using standard techniques'.Holding and handling of the system throughout deployment was found sufficiently described; e.G.The instructions for use state: 'firmly hold the black system stability sheath throughout deployment.Note: do not hold the silver stent delivery sheath at any time during deployment.Do not constrict the stent delivery sheath during stent deployment.' h10: d4 (expiration date: 05/2023), g3, h2, h6 (device) h11: h6 (method, result) h11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : see h10.
|
|
Search Alerts/Recalls
|
|